| Completed | The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and O Influenza, Human | Phase 3 | 2023-11-03 |
| Active Not Recruiting | A Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an Adjuvanted Influenza Vaccine Compar Influenza, Human | Phase 3 | 2023-10-23 |
| Completed | Safety, Reactogenicity, and Immunogenicity Study of a Self-Amplifying MRNA Influenza Vaccine in Healthy Adults Influenza, Human | Phase 1 | 2023-10-05 |
| Completed | Study to Evaluate Immunogenicity, Safety and Tolerability of Adjuvanted and Non-Adjuvanted H2N3 Influenza Vacc Influenza, Human, Infections, Respiratory Tract Infections | Phase 1 | 2023-06-15 |
| Completed | Study to Evaluate Safety and Immunogenicity of Different Priming and Booster Regimens With Adjuvanted H5N8 and Influenza, Human, Infections, Respiratory Tract Infections | Phase 2 | 2023-06-07 |
| Completed | Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥5 Influenza, Human | Phase 2 | 2022-08-25 |
| Completed | A Study to Evaluate Safety and Immunogenicity of One or Two Booster Vaccinations With H5N6 Influenza Vaccine i Influenza, Human, Influenza in Birds, Respiratory Tract Infections | Phase 2 | 2022-07-18 |
| Completed | A Clinical Study to Evaluate the Immunogenicity and Safety of an Adjuvanted Quadrivalent Influenza Vaccine Com Influenza, Human | Phase 3 | 2021-09-30 |
| Completed | Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults Influenza | Phase 2 | 2021-04-13 |
| Completed | A Dose-ranging Pediatric Study of an Adjuvanted Pandemic Influenza Vaccine Influenza, Human | Phase 2 | 2020-12-19 |
| Withdrawn | An Efficacy, Immunogenicity and Safety Study Investigating an Adjuvanted SARS-CoV-2 Influenza Vaccine to Prote Influenza | Phase 2 / Phase 3 | 2020-12-15 |
| Completed | Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults Influenza, Human | Phase 2 | 2020-10-08 |
| Completed | Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects Influenza, Human, Virus Diseases | Phase 3 | 2019-09-06 |
| Completed | Efficacy Study With QIVc in Pediatric Subjects Influenza, Human | Phase 3 | 2019-05-13 |
| Completed | Phase 3 Safety and Immunogenicity Study of aQIV in Elderly Adults Influenza, Human | Phase 3 | 2017-10-17 |
| Completed | Afluria Pregnancy Registry Influenza, Human, Pregnancy, Birth Defect | — | 2017-09-08 |
| Completed | Flucelvax (TIVc or QIVc) Pregnancy Registry Influenza, Human, Pregnancy, Birth Defect | — | 2017-09-01 |
| Completed | Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of QIVc in Subjects ≥2 to <18 Years of Age Influenza, Human | Phase 3 | 2017-05-25 |
| Completed | Clinical Study to Evaluate the Efficacy, Safety and Immunogenicity of an MF59-Adjuvanted Quadrivalent Influenz Influenza | Phase 3 | 2016-09-30 |
| Completed | A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatr Influenza, Human | Phase 3 | 2016-09-27 |
| Completed | A Study to Evaluate Safety, Immunogenicity, and Lot-to-Lot Consistency of H5N1 Subunit Influenza Virus Vaccine Avian Influenza | Phase 3 | 2016-07-11 |
| Completed | Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu V Influenza | Phase 3 | 2016-01-29 |
| Completed | A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatr Influenza, Human | Phase 3 | 2015-09-01 |
| Completed | Clinical Study to Evaluate Safety, Immunogenicity of Investigational Flu Vaccine Compared to an Approved Flu V Influenza | Phase 3 | 2014-10-01 |
| Withdrawn | Flucelvax Pregnancy Registry Pregnant Women, Influenza | — | 2014-09-01 |
| Completed | A Study to Evaluate the Safety and Tolerability of Trivalent Influenza Virus Vaccine in Children Aged 5 Years Influenza, Human | Phase 4 | 2014-09-01 |
| Completed | A Study to Evaluate the Immunogenicity and Safety of bioCSL Quadrivalent Influenza Vaccine (QIV) in Adults Age Influenza, Human | Phase 3 | 2014-08-01 |
| Completed | Safety and Immunogenicity of Different Formulations of an Adjuvanted, Trivalent Subunit Influenza Vaccine in E Influenza | Phase 1 | 2014-06-01 |
| Completed | Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunos Influenza, Human, Flu, Human, Flu, Avian | Phase 3 | 2014-04-01 |
| Completed | Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Underly Influenza, Human | Phase 3 | 2014-04-01 |
| Completed | Safety and Immunogenicity of a Four Influenza Vaccines in Children Ages 6 Months Old to Less Than 48 Months Ol Influenza | Phase 1 / Phase 2 | 2013-12-01 |
| Completed | Clinical Study to Evaluate the Safety, Immunogenicity and Efficacy of Investigational Flu Vaccine Compared to Influenza Virus | Phase 3 | 2013-11-01 |
| Completed | A Study to Assess the Immunogenicity and Safety of CSL's 2013/2014 Formulation of Enzira® Vaccine in Healthy V Influenza, Human | Phase 4 | 2013-05-01 |
| Completed | A Study to Assess the Immunogenicity and Safety of a Trivalent Influenza Vaccine Containing the 2013/2014 Form Influenza, Human | Phase 4 | 2013-05-01 |
| Completed | A Study to Assess the Immunogenicity and Safety of CSL's 2012/2013 Formulation of Enzira® Vaccine in Healthy V Influenza, Human | Phase 4 | 2012-05-01 |
| Completed | A Clinical Trial of CSL's 2010/2011 Formulation of Enzira® in a Healthy Adult Population Influenza | Phase 4 | 2010-05-01 |
| Completed | A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared t Influenza | Phase 3 | 2009-09-01 |
| Completed | A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults in the USA Influenza | Phase 2 | 2009-08-01 |
| Completed | A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Children Influenza Caused by the Novel Influenza A (H1N1) Virus | Phase 2 | 2009-08-01 |
| Completed | A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in a Healthy Pediatric Population in the USA Influenza | Phase 2 | 2009-08-01 |
| Completed | A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults Influenza Caused by the Novel Influenza A (H1N1) Virus | Phase 2 | 2009-07-01 |
| Completed | A Study to Assess the Immunogenicity and Safety of CSL's 2009 / 2010 Formulation of Enzira® Vaccine in Healthy Influenza | Phase 4 | 2009-05-01 |
| Completed | Safety Study of CSL Limited's Influenza Virus Vaccine in the Paediatric Population Aged >= 6 Months to < 18 Ye Influenza | Phase 4 | 2009-03-01 |
| Completed | Dose Ranging Study to Evaluate Immunogenicity and Safety of Adjuvanted or Non-adjuvanted Cell Culture-derived Influenza | Phase 1 | 2008-11-01 |
| Completed | Safety, Tolerability, and Immunogenicity of Different Combinations of Trivalent Influenza Vaccine Varying Infl Influenza | Phase 1 | 2008-10-01 |
| Completed | A Study to Determine the Immunogenicity and Safety Profile of CSL Limited's Influenza Virus Vaccine Compared t Influenza | Phase 4 | 2008-10-01 |
| Completed | A Study of the Efficacy, Safety and Tolerability Profile of CSL Limited's Influenza Virus Vaccine (CSL's IVV) Influenza | Phase 4 | 2008-03-01 |
| Completed | A Phase 2 Study of Immunogenicity, Safety and Tolerability of CSL412 in Elderly Participants Influenza | Phase 2 | 2007-05-01 |
| Completed | Study of a Pandemic Influenza Vaccine in Elderly Participants Influenza | Phase 2 | 2006-10-01 |
| Completed | Study of a Pandemic Influenza Vaccine in Children Influenza | Phase 2 | 2006-09-01 |
| Completed | Phase II Study of Pandemic Influenza Vaccine Influenza | Phase 2 | 2006-07-01 |
| Completed | Study of a Pandemic Influenza Vaccine Influenza | Phase 1 | 2005-10-01 |
| Completed | A Study of the Safety, Tolerability & Immunogenicity of CSL Limited's Influenza Virus Vaccine In a Paediatric Influenza | Phase 3 | 2005-03-01 |